Influence-Tools/republic-os
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity
Files
main
republic-os/legislation/us/states/ca/20232024/ab-347.md
T
Fabio 5a13be122b Legislation: batch E — CA TN VA VT WA WI WV WY 
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
2026-07-06 17:28:36 -04:00

11 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Household product safety: toxic substances: testing and enforcement. (1) Existing law prohibits juvenile products, textile articles, and food packaging that contain specified levels of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from being distributed, sold, or offered for sale in the state, as provided. us/states/ca California Legislature 20232024 AB 347 California AB 347 (20232024)
bill
Household product safety
testing and enforcement
toxic substances
enacted
Ting
16 51 12 2023-01-31 2024-09-29 openstates ocd-bill/668e4081-e46b-44ba-94ff-c0106898058a http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202320240AB347 d74029e1308be7eefb8fb8fb10fb1aaf9d5042055f91f60c6647f14a95d3ea10 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-ca

California AB 347 (20232024) — Household product safety: toxic substances: testing and enforcement.

(1) Existing law prohibits juvenile products, textile articles, and food packaging that contain specified levels of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from being distributed, sold, or offered for sale in the state, as provided.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. 01/31/23 - Introduced (filed) — source
  2. 03/30/23 - Amended Assembly (committee substitute) — source
  3. 04/11/23 - Amended Assembly (committee substitute) — source
  4. 05/18/23 - Amended Assembly (committee substitute) — source
  5. 06/05/24 - Amended Senate (committee substitute) — source
  6. 06/20/24 - Amended Senate (committee substitute) — source
  7. 06/28/23 - Amended Senate (committee substitute) — source
  8. 07/03/24 - Amended Senate (committee substitute) — source
  9. 08/15/24 - Amended Senate (committee substitute) — source
  10. 08/16/23 - Amended Senate (committee substitute) — source
  11. 08/23/24 - Amended Senate (committee substitute) — source
  12. 09/01/23 - Amended Senate (committee substitute) — source
  13. 09/08/23 - Amended Senate (committee substitute) — source
  14. 09/29/24 - Chaptered (committee substitute) — source
  15. AB347 (committee substitute) — source
  16. 09/03/24 - Enrolled (enrolled) — source

Votes

  • AB 347 Ting Assembly Third Reading — 63–10 (pass) · lower
  • Do pass as amended, but first amend, and re-refer to the Committee on [Health] — 5–2 (pass) · upper
  • Do pass and be re-referred to the Committee on [Appropriations] — 7–2 (pass) · lower
  • AB 347 Ting Concurrence in Senate Amendments — 58–14 (pass) · lower
  • Do pass, but first be re-referred to the Committee on [Appropriations] — 5–2 (pass) · upper
  • Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] — 9–0 (pass) · upper
  • Do pass as amended — 5–2 (pass) · upper
  • Placed on suspense file — 7–0 (pass) · upper
  • Placed on suspense file — 7–0 (pass) · upper
  • Do pass as amended — 5–2 (pass) · upper
  • Do pass as amended. — 11–3 (pass) · lower
  • 3rd Reading AB347 Ting et al. By Stern — 30–7 (pass) · upper

Sponsors

  • Ting — primary (person)
  • Allen — coauthor (person)
  • Schiavo — coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2023-01-31 Read first time. To print. reading-1
  • 2023-02-01 From printer. May be heard in committee March 3.
  • 2023-02-09 Referred to Com. on E.S. & T.M. referral-committee
  • 2023-03-30 From committee chair, with author's amendments: Amend, and re-refer to Com. on E.S. & T.M. Read second time and amended. amendment-introduction, amendment-passage, reading-1, reading-2
  • 2023-04-03 Re-referred to Com. on E.S. & T.M. referral-committee
  • 2023-04-11 From committee chair, with author's amendments: Amend, and re-refer to Com. on E.S. & T.M. Read second time and amended. amendment-introduction, amendment-passage, reading-1, reading-2
  • 2023-04-12 Re-referred to Com. on E.S. & T.M. referral-committee
  • 2023-04-19 From committee: Do pass and re-refer to Com. on APPR. (Ayes 7. Noes 2.) (April 18). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
  • 2023-05-10 In committee: Set, first hearing. Referred to APPR. suspense file. referral-committee
  • 2023-05-18 From committee: Amend, and do pass as amended. (Ayes 11. Noes 3.) (May 18). amendment-introduction, amendment-passage, committee-passage
  • 2023-05-18 Read second time and amended. Ordered returned to second reading. amendment-passage, reading-1, reading-2
  • 2023-05-22 Read second time. Ordered to third reading. reading-1, reading-2
  • 2023-05-31 Read third time. Passed. Ordered to the Senate. (Ayes 63. Noes 10. Page 1999.) passage, reading-1, reading-3
  • 2023-06-01 In Senate. Read first time. To Com. on RLS. for assignment. reading-1
  • 2023-06-14 Referred to Com. on E.Q. referral-committee
  • 2023-06-28 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on E.Q. amendment-introduction, amendment-passage, reading-1, reading-2, referral-committee
  • 2023-07-12 From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 2.) (July 12). Re-referred to Com. on APPR. committee-passage, committee-passage-favorable, referral-committee
  • 2023-08-09 In committee: Set, first hearing. Hearing canceled at the request of author.
  • 2023-08-16 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on APPR. amendment-introduction, amendment-passage, reading-1, reading-2, referral-committee
  • 2023-08-17 In committee: Hearing postponed by committee.
  • 2023-08-28 In committee: Referred to APPR suspense file. referral-committee
  • 2023-09-01 From committee: Amend, and do pass as amended. (Ayes 5. Noes 2.) (September 1). amendment-introduction, amendment-passage, committee-passage
  • 2023-09-01 Read second time and amended. Ordered returned to second reading. amendment-passage, reading-1, reading-2
  • 2023-09-05 Read second time. Ordered to third reading. reading-1, reading-2
  • 2023-09-08 Read third time and amended. Ordered to second reading. amendment-passage, reading-1, reading-3
  • 2023-09-11 Read second time. Ordered to third reading. reading-1, reading-2
  • 2023-09-11 Ordered to inactive file at the request of Senator Cortese.
  • 2024-05-21 From inactive file.
  • 2024-05-21 Ordered to second reading.
  • 2024-05-22 Read second time. Ordered to third reading. reading-1, reading-2
  • 2024-06-05 Read third time and amended. Ordered to second reading. amendment-passage, reading-1, reading-3
  • 2024-06-06 Read second time. Ordered to third reading. reading-1, reading-2
  • 2024-06-06 Re-referred to Com. on RLS pursuant to Senate Rule 29.10(c). referral-committee
  • 2024-06-12 Re-referred to Coms. on E.Q. and HEALTH. referral-committee
  • 2024-06-19 From committee: Amend, and do pass as amended and re-refer to Com. on HEALTH. (Ayes 5. Noes 2.) (June 19). amendment-introduction, amendment-passage, committee-passage, referral-committee
  • 2024-06-20 Read second time and amended. Re-referred to Com. on HEALTH. amendment-passage, reading-1, reading-2, referral-committee
  • 2024-07-03 From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 3). amendment-introduction, amendment-passage, committee-passage, referral-committee
  • 2024-07-03 Read second time and amended. Re-referred to Com. on APPR. amendment-passage, reading-1, reading-2, referral-committee
  • 2024-08-05 In committee: Referred to APPR suspense file. referral-committee
  • 2024-08-15 From committee: Amend, and do pass as amended. (Ayes 5. Noes 2.) (August 15). amendment-introduction, amendment-passage, committee-passage
  • 2024-08-15 Read second time and amended. Ordered returned to second reading. amendment-passage, reading-1, reading-2
  • 2024-08-19 Read second time. Ordered to third reading. reading-1, reading-2
  • 2024-08-23 Read third time and amended. Ordered to second reading. amendment-passage, reading-1, reading-3
  • 2024-08-26 Read second time. Ordered to third reading. reading-1, reading-2
  • 2024-08-28 Read third time. Passed. Ordered to the Assembly. (Ayes 30. Noes 7.). passage, reading-1, reading-3
  • 2024-08-28 In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 30 pursuant to Assembly Rule 77.
  • 2024-08-29 Assembly Rule 77 suspended.
  • 2024-08-29 Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 58. Noes 14.). amendment-passage, committee-passage-favorable
  • 2024-09-10 Enrolled and presented to the Governor at 4:30 p.m.
  • 2024-09-29 Approved by the Governor. executive-signature
  • 2024-09-29 Chaptered by Secretary of State - Chapter 932, Statutes of 2024. became-law

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/668e4081-e46b-44ba-94ff-c0106898058a. Confidence: reported (aggregated from official California legislature records).

Reference in New Issue View Git Blame Copy Permalink